Area of research
Pulmonary and Respiratory Medicine · Rheumatology
Research interest
Research interests include Vasculitis and related conditions, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, and T-cell and B-cell Immunology.
Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange
<i>Chlamydia psittaci</i> pneumonia in a patient using ustekinumab therapy for Crohn's disease.
Towards harmonization of autoantibody detection in relation to paraneoplastic neurological syndromes (PNS): a European Survey on laboratory practices.
Autoantibody and biomarker detection in the follow-up of autoimmune diseases: state of the art and future perspectives
International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases
Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells.
An international multicenter retrospective analysis of repeated anti-ENA testing in ANA-associated rheumatic diseases, a data-driven proposal to increase testing efficacy.
Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis.
Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia.
A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways.
T-cell immunity in the experimental autoimmune vasculitis rat model.
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing Performance.
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop.
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.
Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria".
Monitoring patients with celiac disease on gluten free diet: different outcomes comparing three tissue transglutaminase IgA assays.
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis.
Therapeutic Drug Monitoring of Infliximab and Adalimumab through Concentration and Anti-Drug Antibodies Assessment; Comparison of Sanquin Diagnostics and Theradiag Assays.
The International Consensus on ANA Patterns (ICAP): from conception to implementation.
Anti-GABAB receptor encephalitis: clinical and laboratory characteristics, imaging, treatments and prognosis.
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.
Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research.
Cutting edge confusion about cut-off settings in autoimmune diagnostics.
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens.
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP.
Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Multicenter study to compare the diagnostic performance of CLIA vs. FEIA transglutaminase IgA assays for the diagnosis of celiac disease.
Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance technique.